J&J | Le Bénéfice D'Exploitation



Operating Profit Changement Date
AbbVie USD 5.72B 1.98B 2025-06
Abbott USD 2.07B 415M 2025-06
Amgen USD 2.66B 1.37B 2025-06
AstraZeneca USD 3.51B 166M 2025-06
Baxter International USD 272M 214M 2025-06
Bayer EUR 13M 2.31B 2025-06
Becton, Dickinson and Co. USD 979M 433M 2025-06
Biogen USD 851.8M 540.6M 2025-06
Boston Scientific USD 942M 21M 2025-06
Bristol-Myers Squibb USD 3.77B 366M 2025-06
CONMED USD 38.16M 22.2M 2025-06
Cooper Companies USD 184.8M 2.8M 2025-04
Dexcom USD 212.6M 78.9M 2025-06
Edwards Lifesciences USD 430.9M 36.1M 2025-06
Eli Lilly USD 7.02B 1.61B 2025-06
Gilead Sciences USD 2.7B 467M 2025-06
GlaxoSmithKline GBP 2.02B 193M 2025-06
Globus Medical USD -125953000 222.96M 2025-06
Hologic USD 260.9M 267.9M 2025-06
Insulet USD 121.1M 71.8M 2025-06
Integra LifeSciences USD -1309000 14.65M 2025-06
Intuitive Surgical USD 746.9M 168.8M 2025-06
J&J USD 6.94B 6.69B 2025-06
Medtronic USD 1.44B 210M 2025-04
Merck USD 6.36B 494M 2025-06
Merit Medical Systems USD 47.02M 5.99M 2025-06
Novartis USD 4.86B 201M 2025-06
Pfizer USD 2.6B 1.06B 2025-06
Regeneron Pharmaceuticals USD 1.08B 487.8M 2025-06
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 1.71B 573M 2025-06
Stryker USD 1.17B 331M 2025-06
Tandem Diabetes Care USD -31859000 89.02M 2025-06
Teva Pharmaceutical Industries USD 899M 380M 2025-06
Vertex Pharmaceuticals USD 1.15B 123.1M 2025-06
Zimmer Biomet Holdings USD 396.4M 57.5M 2025-06
Zoetis USD 1.02B 205M 2025-06


J&J Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.